Literature DB >> 18825658

Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.

M E Barber1, V Save, F Carneiro, S Dwerryhouse, P Lao-Sirieix, R H Hardwick, C Caldas, R C Fitzgerald.   

Abstract

Hereditary diffuse gastric cancer (HDGC) is caused by germline E-cadherin (CDH1) mutations in 25-40% of tested families. Management options for asymptomatic mutation carriers are fraught, since endoscopic surveillance can miss cancer foci and prophylactic gastrectomy has profound clinical sequelae. The aims of this study were to evaluate the impact of current surveillance practices on pre-operative diagnosis and to characterize the microscopic lesions in gastrectomy specimens to better inform clinical practice. Histological assessment and mapping of endoscopic surveillance and gastrectomy specimens were performed for eight asymptomatic CDH1 mutation carriers. E-cadherin expression and proliferation were analysed and evidence of epithelial-mesenchymal transition (EMT) was sought by immunohistochemistry for vimentin and cytokeratin 8/18. Four of eight patients had lesions detected at endoscopic surveillance. A median of 20.5 (range 0-66) signet ring foci were identified per gastrectomy (including in situ lesions and pagetoid spread). Foci were predominantly identified in the fundus and body (90% endoscopic biopsies and 85% in gastrectomy). The likelihood of detecting foci pre-operatively was positively correlated with the number of biopsies taken and the number of lesions in the gastrectomy specimen. E-cadherin expression in gastrectomy specimens was reduced or absent in all of the foci compared with the intervening gastric tissue, suggesting that these lesions are polyclonal. The foci had a low proliferative index (<2%) and there was no evidence for EMT. Multiple endoscopic biopsy sampling of the gastric mucosa increases the yield of microscopic cancer foci. The low proliferative index and lack of EMT suggests that these foci may represent an indolent stage of HDGC. (c) 2008 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18825658     DOI: 10.1002/path.2415

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

Review 2.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

Review 3.  Gastric pseudo-signet ring cells: a potential diagnostic pitfall.

Authors:  Caroline Hughes; Godman Greywoode; Runjan Chetty
Journal:  Virchows Arch       Date:  2011-08-12       Impact factor: 4.064

Review 4.  Hereditary gastric cancer.

Authors:  F Carneiro
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 5.  [Hereditary gastric and pancreatic cancer].

Authors:  C Langner
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

Review 6.  Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

Authors:  María Sereno; Cristina Aguayo; Carmen Guillén Ponce; César Gómez-Raposo; Francisco Zambrana; Miriam Gómez-López; Enrique Casado
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

Review 7.  Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.

Authors:  Parry Guilford; Bostjan Humar; Vanessa Blair
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

8.  [Hereditary gastric cancer].

Authors:  E-M Wolf; J B Geigl; M Svrcek; M Vieth; C Langner
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

Review 9.  Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

10.  Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC).

Authors:  Carla Oliveira; Raquel Seruca; Nicoline Hoogerbrugge; Marjolijn Ligtenberg; Fátima Carneiro
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.